Clinical Trials DEA Events 
NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.
Veriheal
JUNE 30, 2023
For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
AUGUST 16, 2021
and industry-leading Cannabis Business Times, Cannabis Dispensary, and Hemp Grower magazines, announces today President of Scottsdale Research Institute (SRI) Sue Sisley, MD, as the keynote speaker on Day 2 of its annual event, to take place Aug. 24-26, 2021, at Paris Las Vegas Hotel & Casino. 25 from 11 a.m. – 24-26, 2021.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. Rick Doblin, Ph.D., and Michael Mithoefer, M.D., Lyle Craker, Ph.D.,
Cannabis Law Report
MARCH 2, 2020
This renewed interest in psychedelics is being sparked by a pair of seemingly unrelated events. Any approved medicines will have to be rescheduled by the Drug Enforcement Administration (DEA). Hundreds of other U.S. cities are reportedly considering similar measures at the moment. The dawn of a new era in psychedelic medicine.
Cannabis Law Report
APRIL 13, 2022
Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Hosting clinical trials for MDMA ( MAPS Public Benefit Corporation), psilocybin (the Usona Institute), LSD (MindMed) and ketamine (the University of Utah ).
Veriheal
JUNE 26, 2025
Veterans, members of the LGBTQIA community , and women are disproportionately impacted due to their positions of vulnerability to traumatic events, such as life-threatening violence or sexual assault. Methodological Concerns with Blinding A particular concern raised by the FDA is the lack of effective blinding in the clinical trials.
Expert insights. Personalized for you.
104 
Let's personalize your content